December 7, 2016
All health care facilities, particularly in the care of children, should take antimicrobial stewardship programs and rapid molecular diagnostic platforms into consideration to reduce the burden of multidrug-resistant and carbapenem-resistant Pseudomonas aeruginosa, according to study findings.
“As in adults, serious and systemic, often opportunistic, infections are substantial in children with critical illness, in those who require ventilator support, and in patients who are immunocompromised and/or have a hematologic-oncologic disease,” Latania K. Logan, MD, of the departments of pediatrics and internal medicine, division of infectious diseases at Rush Medical College, Rush University Medical Center, and colleagues wrote.
“The majority of P. aeruginosa studies have examined the effect of these infections on patients of cystic fibrosis. Despite the annual numbers of infection and rising rates of antibiotic resistance, no pediatric studies have assessed national or regional trends in MDR or carbapenem-resistant P. aeruginosa.”